National Hepatitis B Alliance - NHBA

• 1: Home
• 2: About the Alliance
• Current page is 3: Members and Partners
  • 3.1: Business
• 4: Research
• 5: Conferences
• 6: Policy Documents
• 7: Guidelines
• 8: Resources
• 9: Media
• 10: Site Map

Latest News

Alliance Members and Partners

Structure

• Executive
• Alliance (Executive + Organisational Members)
• Clinical Reference Panel and invited individuals
• Invited organisational guests/observers
• Stakeholders correspondents

Executive

• Australian Council of Chinese Medical Associations (ACCMA) - Ida Soo
• Gastroenterological Society of Australia / Australian Liver Association (ALA/GESA) - Darrell Crawford
• Australasian Society for HIV Medicine (ASHM) - Sharon Lewin
• Hepatitis Australia - Helen Tyrrell
• The Cancer Council of Australia (CCA) - Andrew Penman
• Secretariat - Levinia Crooks

Organisational Members

• Advancing the Clinical Treatment of Hepatitis B Virus (ACT-HBV)
• Anex (Association for Prevention and Harm Reduction Programs)
• Australasian Society for HIV Medicine (ASHM)
• Australasian Hepatology Association (AHA)
• Australian Council of Chinese Medical Associations (ACCMA)
• Australian General Practice Network (AGPN)
• Australian Research Centre in Sex, Health and Society (ARCSHS)
• The Cancer Council of Australia (CCA)
• Ethnic Communities Council of Queensland (ECCQ)
• Gastroenterological Society of Australia / Australian Liver Association (GESA/ALA)

• Hepatitis Australia (HA)
• Multicultural HIV/AIDS and Hepatitis C Service (MHAHS)
• National Centre in HIV Epidemiology and Clinical Research (NCHECR)
• National Centre in HIV Social Research (NCHSR)
• NSW Refugee Health Service (RHS)
• St Vincents Hospital Melbourne (SVHM)
  
• Victorian Infectious Diseases Reference Laboratory (VIDRL)

• Consumer Representative

Clinical Reference Panel

Panel Members are invited to attend and observe meetings of the Alliance

• Robert Batey
• Wendy Cheng
• Graham Cooksley
• Benjamin Cowie
• Paul Desmond
• Hugh Harley
• Miriam Levy
• Graeme McDonald
• Stuart Roberts
• Joe Sasadeusz

Invited Organisational Observers and Stakeholder Correspondents

These organisations are invited to send a nominee or observer to attend meetings of the Alliance and may be provided with minutes of these

• Cultural and Country-based Medical Associations
• Divisions of General Practice
• Members of the Clinical Panel and Invited Individuals

• Other Organisations/Individuals as Identified

Corresponding Members

Individuals and organisations who join the Alliance as corresponding members and as such are alerted to activities undertaken by the Alliance.

• Ethnic Communities Council of Queensland
• Victorian Hepatitis B Working Group
  

Autonomy

The Alliance will comprise:

• organisations with an interest, expertise and capacity in hepatitis B and
• individuals with a specific contribution to make to its agenda

The Alliance will encourage participation in its activities by:

• inviting individuals or organisations to attend its meetings as guests/observers
• distributing its proceedings (or some sub set of these) to a broader group of stakeholders (correspondents) as needed

The Alliance will not invite pharmaceutical industry staff or principles to join it, but may liaise with these individuals and invite them to observe or participate in some or all parts of its meetings

• The Alliance will not invite commonwealth, state or territory government bureaucrats to join it, but recognizes that many members will be employees of government or employed on government funded projects
• These individuals will not be asked to act as representatives of their governments

Support for the Alliance

The Alliance receives no government funding, though it will seek government funding for hepatitis B initiatives and advocate for the funding of treatment, support, prevention, education, and research in hepatitis B.

The Alliance may seek support financially, and/or in kind, from its members, industry, government and non-government sources to achieve its goals.

It will use opportunities offered by industry, research and scientific meetings on hepatitis B and related topics to allow it to meet, in order to further its mission, aims, and objectives.

Any funds accepted by the Alliance will be unencumbered and in the case of funds from pharmaceutical industry would be requested and received as an educational or research grant.